Nicholas Capman is the CEO of The FDA Group, a life science consulting firm. In addition to assisting some of the largest and most recognized life science companies, Nicholas and his firm have contributed to many media outlets on the topic of FDA regulations, such as Fox Business, Bloomberg, CNN, MSNBC, The New York Times, and the Associated Press. The FDA Group is a two-time Boston Business Journal Fast 50 recipient and has been included on the Inc. 5000 list four years in a row under Nicholas’s leadership.